Gomberg-Maitland M - Search Results

1

Traditional and alternative designs for pulmonary arterial hypertension trials.

Gomberg-Maitland M. Gomberg-Maitland M. Proc Am Thorac Soc. 2008 Jul 15;5(5):610-6. doi: 10.1513/pats.200803-024SK. Proc Am Thorac Soc. 2008. PMID: 18625753 Review.

2

Prostacyclin therapy for pulmonary arterial hypertension: new directions.

Gomberg-Maitland M, Preston IR. Gomberg-Maitland M, et al. Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154. Semin Respir Crit Care Med. 2005. PMID: 16121316 Review.

3

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ. Gomberg-Maitland M, et al. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. doi: 10.1164/rccm.200505-766OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151039 Clinical Trial.

4

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.

Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S. Gomberg-Maitland M, et al. Am J Cardiol. 2005 Nov 1;96(9):1334-6. doi: 10.1016/j.amjcard.2005.06.083. Epub 2005 Sep 16. Am J Cardiol. 2005. PMID: 16253609 Clinical Trial.

5

Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?

Jacobs A, Preston IR, Gomberg-Maitland M. Jacobs A, et al. Curr Med Res Opin. 2006 Dec;22(12):2567-74. doi: 10.1185/030079906X158020. Curr Med Res Opin. 2006. PMID: 17166339 Review.

6

Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.

Gomberg-Maitland M, Huo D, Benza RL, McLaughlin VV, Tapson VF, Barst RJ. Gomberg-Maitland M, et al. J Heart Lung Transplant. 2007 Jul;26(7):732-8. doi: 10.1016/j.healun.2007.04.013. Epub 2007 Jun 13. J Heart Lung Transplant. 2007. PMID: 17613405 Clinical Trial.

7

A USA-based registry for pulmonary arterial hypertension: 1982-2006.

Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. Thenappan T, et al. Eur Respir J. 2007 Dec;30(6):1103-10. doi: 10.1183/09031936.00042107. Epub 2007 Sep 5. Eur Respir J. 2007. PMID: 17804449 Free article.

8

United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads DM, McKenna SP. Gomberg-Maitland M, et al. J Heart Lung Transplant. 2008 Jan;27(1):124-30. doi: 10.1016/j.healun.2007.10.004. J Heart Lung Transplant. 2008. PMID: 18187098

9

Prostacyclin therapies for the treatment of pulmonary arterial hypertension.

Gomberg-Maitland M, Olschewski H. Gomberg-Maitland M, et al. Eur Respir J. 2008 Apr;31(4):891-901. doi: 10.1183/09031936.00097107. Eur Respir J. 2008. PMID: 18378784 Free article. Review.

10

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

Gomberg-Maitland M, Maitland ML, Barst RJ, Sugeng L, Coslet S, Perrino TJ, Bond L, Lacouture ME, Archer SL, Ratain MJ. Gomberg-Maitland M, et al. Clin Pharmacol Ther. 2010 Mar;87(3):303-10. doi: 10.1038/clpt.2009.217. Epub 2009 Dec 9. Clin Pharmacol Ther. 2010. PMID: 20010555 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters